Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-DNA Damaging Decitabine for MDS
NCT01165996Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Jul 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine in myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia (CMML), sponsored by Case Comprehensive Cancer Center. Started Jul 2010; status: completed.
02
Drugs
decitabine
03
Conditions
myelodysplastic syndrome (MDS)chronic myelomonocytic leukemia (CMML)
Beyond the preview
Go deeper on NCT01165996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01165996.